ASCENDIS PHARMA A/S: Financial statements 2018
CVR: 29918791
Source: annual report 2018, Danish Business Authority
01/01/2018 – 31/12/2018
ASCENDIS PHARMA A/S (CVR 29918791) has filed annual accounts for 2018. In 2018, the company reported revenue of EUR 10,581,000 and a net result of EUR -130,097,000 compared with EUR -123,897,000 the year before. That is an increase of 591.6% compared with the year before. The profit margin was -1,229.5%. Equity in the 2018 report amounted to EUR 280,050,000. The solvency ratio was 87.8%.
- Revenue
- EUR 10,581,000
- Profit/Loss
- EUR -130,097,000
- Equity
- EUR 280,050,000
- Total Assets
- EUR 318,968,000
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | 10.6 mio. EUR | - | -130.1 mio. EUR | 280.1 mio. EUR | - |
| 2017 | 1.5 mio. EUR | - | -123.9 mio. EUR | 187.2 mio. EUR | - |
| 2016 | 4.6 mio. EUR | - | -68.5 mio. EUR | 176.6 mio. EUR | - |
| 2015 | 8.1 mio. EUR | - | -32.9 mio. EUR | 120.3 mio. EUR | - |
| 2014 | 14 mio. EUR | - | -9.7 mio. EUR | 45.8 mio. EUR | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
As of November 2, 2018, Lars Holtug has joined the board of directors of ASCENDIS PHARMA A/S.
As of September 12, 2018, Martin Olin has left the board of directors of ASCENDIS PHARMA A/S.
ASCENDIS PHARMA A/S has published its annual report for 2017. Revenue came to DKK 1,530,000, and the net result was DKK -123,897,000.
As of May 29, 2018, Jonathan Silverstein has left the board of directors of ASCENDIS PHARMA A/S.
About ASCENDIS PHARMA A/S
ASCENDIS PHARMA A/S is a Danish company of the type Aktieselskab based in Hellerup, founded in 2006. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named ASCENDIS PHARMA ApS and CADENZA PARTNERS ApS. The management consists of Jan Møller Mikkelsen, Anni Lotte Kirstine Pedersen and Michael Wolff Jensen. The board consists of Albert Cha (chair), Jan Møller Mikkelsen, Jean-Jacques Bienaime and Lars Holtug. The company is owned by Cede & Co. The company has 688 employees (2026). In 2025, the company reported revenue of EUR 720,132,000 and a net result of EUR -228,034,000 compared with EUR -378,084,000 the year before. Equity in the 2025 report amounted to EUR -162,821,000.